In another research, Melamed et al. [146] developed PEI–SNAs for targeting the Gli1 oncogene, a transcriptional activator within the Hedgehog signaling pathway which is crucial for the maintenance of glioma stem cells (GSCs) and also plays a key role in the development and chemo-resistant of GBM. This evidence concerns the gene GLI1 and glioblastoma.